Ignite Creation Date:
2025-12-24 @ 7:00 PM
Ignite Modification Date:
2025-12-25 @ 4:33 PM
Study NCT ID:
NCT01740557
Status:
COMPLETED
Last Update Posted:
2024-10-08
First Post:
2012-11-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-21
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-30
First Submit QC Date:
None
Study First Post Date:
2012-12-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-11-03
Results First Submit QC Date:
None
Results First Post Date:
2024-10-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-18
Last Update Post Date:
2024-10-08
Last Update Post Date Type:
ACTUAL